Tish Technologies

Tish Technologies is a biotechnology company specializing in the development of advanced drug delivery systems designed to enhance the bioavailability of poorly soluble compounds. The company is best known for its proprietary Hydro-Q-Sorb technology, which utilizes a hydrosoluble delivery system to improve the absorption of lipophilic substances like Coenzyme Q10. Tish Technologies focuses on applying its formulation expertise to both pharmaceutical and nutraceutical products to optimize therapeutic efficacy. Notably, the company has received Orphan Drug Designation from the FDA for its ubiquinone formulations in the treatment of mitochondrial encephalomyopathies. Their work spans from early-stage formulation development to licensing their delivery platforms to global partners. By addressing the challenges of lipid solubility, the company enables the creation of more effective health and wellness products.